India  

U.S. hands Novavax $1.6b to work on COVID-19 vaccine

Video Credit: Reuters Studio - Duration: 02:12s - Published
U.S. hands Novavax $1.6b to work on COVID-19 vaccine

U.S. hands Novavax $1.6b to work on COVID-19 vaccine

The U.S. government awarded $1.6 billion to help Novavax quickly come up with a potential novel coronavirus vaccine, sending the stock surging more than 30 percent.

Conway G.

Gittens has more.


You Might Like


Related videos from verified sources

Biotech Company Novavax Says Its COVID-19 Vaccine Trials Are Show Promise [Video]

Biotech Company Novavax Says Its COVID-19 Vaccine Trials Are Show Promise

Maryland-based biotech company Novavax briefed the public on the progress of its vaccine candidate Tuesday.

Credit: WJZ Baltimore     Duration: 01:39Published
U.S. Gives $1.6B to Novavax to Deliver 100M Doses of Potential COVID-19 Vaccine by 2021 [Video]

U.S. Gives $1.6B to Novavax to Deliver 100M Doses of Potential COVID-19 Vaccine by 2021

At $1.6 billion, Novavax receives the largest amount the Trump administration has awarded to a company to manufacture millions of doses of a coronavirus vaccine set to be delivered by January...

Credit: Veuer     Duration: 01:20Published